과학 실험실
과학 실험실

JPL934™

Clinically Proven
Probiotics Blend

Clinically Proven Probiotics Blend which can improve bowel movement, gut health, and lower gastrointestinal symptoms.

Lactobacillus johnsonii IDCC 9203

Lactobacillus plantarum IDCC 3501

Bifidobacterium lactis IDCC 4301

Human Clinical Test Details of JPL934™

과학 실험실

Improvement in Overall

Symptoms at Week 8

A significantly higher relief of overall lower abdominal symptoms was observed in the ID-JPL934 group than in the placebo group in the intention-to-treat analysis. This result was also significant in per-protocol analysis.

그림13.png

Relief of overall symptoms in the ID-JPL934 group vs. placebo group after 8-week treatment.

시험관을 가진 과학자

Changes in

Lower Abdominal Symptoms 

A comparison of the two groups for changes in stool form, stool frequency, and abnormal bowel movement symptoms from baseline to week 8 revealed a higher decrease in abdominal pain and bloating in the ID-JPL934 group than in the placebo group, suggesting significant differences between the two groups.

그림11.png

Comparison of changes in stool form, frequency of bowel movements per day, and abnormal bowel movement symptoms from baseline to week 8 between the 2 groups.

Metagenomic analysis of

participants’ fecal samples.

The levels of serum IL-6 were significantly decreased in the ID-JPL934 group after the treatment, while no significant changes were found in the levels of the placebo group, and the difference was significant.

그림12.png

Effects of ID-JPL934 on blood levels of IL-6

실험실

Analysis of quantitative changes

in probiotic levels of feces

Higher levels of species-specific sequences associated with probiotic formulations were detected in the fecal DNAs of subjects treated with ID-JPL934 than in those in the placebo group, based on quantitative polymerase chain reaction (qPCR) results.

그림10.png

Quantitative changes in fecal probiotic levels at baseline and at week 8.